IHS Chemical Week

Regions :: North Asia :: Taiwan

ScinoPharm to Invest in U.S. Biologics Firm

12:04 AM MDT | September 1, 2010 | Deepti Ramesh

Active pharmaceutical ingredients (APIs) manufacturer ScinoPharm (Shan-Hua, Taiwan) says it will invest in Tanvex Biologics (Irvine, CA), which specializes in the development of biosimilars and biobetters, as well as the provision of contract research and contract manufacturing services for biologics. ScinoPharm's investment is in the form of tangible assets, intellectual properties, as well as cash, the company says. Financial details of the deal were not disclosed. Tanvex is currently establishing a cGMP facility at San Diego, CA and will have research centers...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa